Cidara Therapeutics Inc (CDTX)
19.00
+1.55
(+8.88%)
USD |
NASDAQ |
Nov 22, 10:51
Cidara Therapeutics Market Cap: 133.89M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 122.96M |
| November 20, 2024 | 106.54M |
| November 19, 2024 | 110.14M |
| November 18, 2024 | 105.42M |
| November 15, 2024 | 101.26M |
| November 14, 2024 | 102.03M |
| November 13, 2024 | 97.95M |
| November 12, 2024 | 94.78M |
| November 11, 2024 | 94.07M |
| November 08, 2024 | 95.13M |
| November 07, 2024 | 92.38M |
| November 06, 2024 | 93.44M |
| November 05, 2024 | 93.44M |
| November 04, 2024 | 91.82M |
| November 01, 2024 | 92.24M |
| October 31, 2024 | 91.61M |
| October 30, 2024 | 90.41M |
| October 29, 2024 | 94.35M |
| October 28, 2024 | 87.87M |
| October 25, 2024 | 88.79M |
| October 24, 2024 | 78.64M |
| October 23, 2024 | 79.63M |
| October 22, 2024 | 80.19M |
| October 21, 2024 | 79.06M |
| October 18, 2024 | 79.34M |
| Date | Value |
|---|---|
| October 17, 2024 | 78.57M |
| October 16, 2024 | 75.68M |
| October 15, 2024 | 71.66M |
| October 14, 2024 | 72.58M |
| October 11, 2024 | 74.76M |
| October 10, 2024 | 74.13M |
| October 09, 2024 | 76.46M |
| October 08, 2024 | 75.47M |
| October 07, 2024 | 78.43M |
| October 04, 2024 | 76.81M |
| October 03, 2024 | 75.40M |
| October 02, 2024 | 74.34M |
| October 01, 2024 | 74.76M |
| September 30, 2024 | 75.75M |
| September 27, 2024 | 75.59M |
| September 26, 2024 | 75.94M |
| September 25, 2024 | 76.15M |
| September 24, 2024 | 75.80M |
| September 23, 2024 | 76.51M |
| September 20, 2024 | 79.32M |
| September 19, 2024 | 82.49M |
| September 18, 2024 | 81.78M |
| September 17, 2024 | 81.85M |
| September 16, 2024 | 83.05M |
| September 13, 2024 | 84.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
29.55M
Minimum
May 13 2022
176.24M
Maximum
Mar 21 2023
88.78M
Average
89.83M
Median
Jul 31 2023
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.17B |
| Arbutus Biopharma Corp | 658.48M |
| GlycoMimetics Inc | 20.36M |
| FibroGen Inc | 39.60M |
| Cue Biopharma Inc | 67.47M |
Market Cap Related Metrics
| PS Ratio | 1.561 |
| PEG Ratio | -0.0010 |
| Price to Book Value | 1.158 |
| Price | 19.00 |
| Earnings Yield | -133.5% |
| PEGY Ratio | -0.0010 |